Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis. Currently, Yuyu Pharma has two new drug discovery programs targeting benign prostatic hyperplasia (BPH) and dry eye syndrome. Yuyu Pharma also has various Over-the-counter drugs and dietary supplements, such as YupanC® (vitamin C), Venoplus® (ointment), and Venapollo® (multivitamins)
Company Details
- Employees
- 192
- Founded
- -
- Address
- 197 Dongho-Ro, Jung-Gu, Seoul,. 04598,korea, Republic Of
- Phone
- +02)2253-6600
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- yuyu.co.kr
- HQ
- Seoul, .
Yuyu Pharma Questions
Yuyu Pharma's helpline number is +02)2253-6600
Yuyu Pharma's website is yuyu.co.kr
Yuyu Pharma's LinkedIn profile is https://kr.linkedin.com/company/yuyu-pharma
Yuyu Pharma has
192 employees.
View email and phone details for 192
employees at Yuyu Pharma.
Yuyu Pharma's industry is
Pharmaceutical Manufacturing
Yuyu Pharma's top competitors are
Koru Pharma Co., Ltd.,
Sn Bioscience,
Samjin Pharm,
Chong Kun Dang Pharm.,
Yuyu Pharma Us,
Yuyu Healthcare,
Daewoong Pharmaceutical,
Nexus Pharma Co., Ltd.,
Lotte Biologics,
Hanmi Pharmaceuticals.
Yuyu Pharma's categories are Pharmaceutical Manufacturing
Yuyu Pharma's founding year is 1941
